CHOISTECHNOLOGY Wins CES 2026 Innovation Award, Drawing Global Attention with Thermosafer XST600

Hello, this is CHOISTECHNOLOGY., Ltd.

The world’s largest IT and consumer electronics exhibition, CES 2026, which presents global innovation and sets the direction for future industries, was held this past January in Las Vegas, USA. Under the theme “Innovators Show Up,” CES 2026 served as a global platform where innovative companies that solve real-world challenges and drive industrial transformation through technology gathered to share their visions for the future.

CHOISTECHNOLOGY participated in CES 2026, showcasing its body temperature monitoring solution, Thermosafer, and attracted strong attention from global visitors and buyers by highlighting safety and continuity in medical and healthcare environments, as well as its applicability in real clinical settings. Through this participation, the company once again confirmed its technological competitiveness as a medical innovation company and its potential for global market expansion.

CHOISTECHNOLOGY Wins CES Innovation Award with ‘Thermosafer(Thermosafer XST600)’

At CES 2026, CHOISTECHNOLOGY achieved a notable milestone by receiving the CES 2026 Innovation Award in the “Human Security for All” category. This recognition represents international acknowledgment of CHOISTECHNOLOGY’s achievement in simultaneously enhancing safety and efficiency in medical settings through its non-invasive, wireless, continuous core body temperature monitoring device, Thermosafer (Thermosafer XST600). Thermosafer is designed to be attached to a patient’s skin to continuously measure core body temperature and to transmit measurement data in real time to hospital systems (EMR) through integration with patient monitoring devices.

Building on this award, CHOISTECHNOLOGY plans to further strengthen its position in the global medical market as a company that contributes to the promotion of human health and safety through technology—values aligned with the vision of “Human Security for All.”

Strong Interest in ‘Thermosafer’ from Global Medical and Healthcare Professionals

During CES 2026, CHOISTECHNOLOGY conducted on-site consultations with global medical and healthcare professionals, focusing on the technological differentiation and real clinical application cases of its non-invasive, wireless body temperature monitoring device, Thermosafer. In particular, the ability to continuously measure core body temperature in a non-invasive manner and to integrate with hospital systems in real time drew strong interest and positive responses from numerous healthcare professionals and buyers. 

Specific inquiries followed regarding its applicability in operating rooms and intensive care units, reduced patient burden compared to conventional invasive thermometers, and ease of installation and operation enabled by its wireless design. In-depth discussions were also held on implementation scenarios and system integration methods for actual hospital adoption. In addition, medical device distributors and hospital representatives evaluated Thermosafer as a highly competitive and differentiated solution within their product portfolios.

Through on-site engagement at CES 2026, CHOISTECHNOLOGY directly identified the technological standards and needs of the global medical market, while also validating Thermosafer as a solution that can be immediately applied in real medical environments. Based on these outcomes, the company plans to gradually expand discussions on potential collaboration with overseas medical institutions and partner companies.

CES 2026 Innovation Award Leads to Global Media Coverage

During CES 2026, CHOISTECHNOLOGY attracted the attention of global media, conducting interviews and media coverage with local and international professional outlets, including AVING News. On-site interviews focused on the development background of Thermosafer, its technological differentiation, and the key challenges it was designed to address in medical settings.

Media representatives showed strong interest in the system’s ability to continuously measure core body temperature in a non-invasive manner and its real-time integration with hospital EMR systems. Active discussions also took place regarding the background of the CES 2026 Innovation Award recognition and its alignment with the values pursued by the “Human Security for All” category. Through these interviews, CHOISTECHNOLOGY conveyed its technology philosophy grounded in a clear commitment to patient safety and medical efficiency.

Exploring Global Collaboration Through Networking with Key Stakeholders

During its participation in CES 2026, CHOISTECHNOLOGY went beyond exhibition activities by actively engaging in various global networking programs, expanding opportunities for meaningful exchange aimed at overseas expansion. In particular, the company participated in dinners and meetings with a visiting delegation of National Assembly members, providing opportunities for direct communication with key domestic and international stakeholders. Attendees included eight National Assembly members—Nam In-soon, Lee Cheol-gyu, Lee Eon-ju, Choi Min-hee, Kim Won-yi, Maeng Sung-gyu, and Choi Hyung-woo—along with the Head of KOTRA’s North America Regional Headquarters and representatives from government and related institutions. Broad discussions were held on overseas expansion strategies for Korean companies and the global competitiveness of innovative technologies.

In addition, CHOISTECHNOLOGY participated in CES 2026 as part of the Incheon Free Economic Zone Authority (IFEZ) delegation and attended the “CES 2026 Incheon Night” networking event. The event brought together Incheon-based exhibitors, overseas companies, investors, and industry professionals to discuss partnership opportunities and directions for collaboration. Substantive business exchanges took place, centered on technology briefings and product demonstrations, enabling Chois Technology to secure multiple initial touchpoints and networks for global market entry.

These networking activities went beyond simple exchanges, serving as an opportunity to deepen understanding of the policy environment and support systems required for small and medium-sized enterprises entering global markets. Through CES 2026, CHOISTECHNOLOGY expanded its global network while laying a foundation for exploring future overseas partnerships and collaborations.

Concluding CES 2026 Amid Strong Global Interest

Participation in CES 2026 marked a meaningful journey for CHOISTECHNOLOGY, demonstrating the global competitiveness of its medical technologies while organically linking exhibition activities, media exposure, and networking into tangible outcomes. Rather than stopping at a technology showcase, CHOISTECHNOLOGY validated the value of Thermosafer on site as a solution that addresses real challenges in medical environments.

Going forward, CHOISTECHNOLOGY will continue to pursue technology innovation based on the needs of medical settings and grow as a smart healthcare company that enhances both safety and efficiency through expanded global partnerships and phased entry into overseas markets.

Thank you.